Agios Pharmaceuticals (AGIO) Q3 2020 Earnings

30JulConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-1.81
-1.4
-1
-0.59

Details

Expected EPS
-1.37
Actual EPS
-1.31
Surprise EPS
0.06
Surprise Percent
+4.38%

Description

Agios Pharmaceuticals (AGIO) has reported earnings of -1.31 per share for Q3 2020.

0 Comments

Share your thoughts